Alzoubaidi Mohammed, Mokhlesi Babak
Section of Pulmonary and Critical Care, Sleep Disorders Center, University of Chicago, Chicago, Illinois, USA.
Curr Opin Pulm Med. 2016 Nov;22(6):545-54. doi: 10.1097/MCP.0000000000000319.
Obstructive sleep apnea (OSA) is a highly prevalent condition that has been associated with cardiovascular morbidity and mortality, impaired glucose metabolism and daytime functional impairment. Compared with nonrapid eye movement sleep, rapid eye movement (REM) sleep is associated with higher sympathetic activity and cardiovascular instability in healthy individuals and more so in patients with OSA.
Recent studies have indicated that REM OSA is independently associated with prevalent and incident hypertension, nondipping of nocturnal blood pressure, increased insulin resistance and impairment of human spatial navigational memory.
These findings have significant clinical implications for the duration of continuous positive airway pressure (CPAP) use that is needed to decrease the health risks associated with OSA. Further research is needed to establish the duration of CPAP needed to effectively treat REM OSA and to evaluate patients with REM OSA with an overall normal apnea-hypopnea index.
阻塞性睡眠呼吸暂停(OSA)是一种高度常见的病症,与心血管疾病的发病率和死亡率、葡萄糖代谢受损以及日间功能障碍相关。与非快速眼动睡眠相比,快速眼动(REM)睡眠在健康个体中与更高的交感神经活动和心血管不稳定相关,在OSA患者中更是如此。
近期研究表明,快速眼动睡眠期OSA与普遍存在的和新发的高血压、夜间血压非勺型变化、胰岛素抵抗增加以及人类空间导航记忆受损独立相关。
这些发现对于降低与OSA相关的健康风险所需的持续气道正压通气(CPAP)使用时长具有重要的临床意义。需要进一步研究来确定有效治疗快速眼动睡眠期OSA所需的CPAP时长,并评估总体呼吸暂停低通气指数正常的快速眼动睡眠期OSA患者。